Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

CUSIP: 185063104

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
76,991,404
Total 13F shares
14,258,408
Share change
+1,509,269
Total reported value
$39,064,022
Price per share
$2.74
Number of holders
39
Value change
+$4,324,341
Number of buys
15
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 185063104?
CUSIP 185063104 identifies CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2020

As of 31 Dec 2020, Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,258,408 shares. The largest 10 holders included RTW INVESTMENTS, LP, Carmignac Gestion, VANGUARD GROUP INC, Acuta Capital Partners, LLC, AJU IB Investment Co., Ltd., BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and FIRST MANHATTAN CO. This page lists 39 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.